Hippo (HIPO) CEO sells 5,000 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

Hippo Holdings Inc. Chief Executive Officer Richard McCathron executed an open-market sale of 5,000 shares of Common Stock at $25.86 per share. The transaction was carried out on the basis of a Rule 10b5-1 trading plan dated August 29, 2025, indicating it was pre-arranged. Following this sale, he directly holds 615,650 shares, which the disclosure notes include 343,868 restricted stock units (RSUs).

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares ($129,300)

Net Sell 1 txn

Insider McCathron Richard

Role Chief Executive Officer

Sold 5,000 shs ($129K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$25.86	$129K

Holdings After Transaction: Common Stock — 615,650 shares (Direct)

Footnotes (1)

1. Sales were effected pursuant to a Rule 10b5-1 trading plan dated August 29, 2025. Includes 343,868 RSUs.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCathron Richard

(Last) (First) (Middle)

C/O HIPPO HOLDINGS INC. 1 ALMADEN BLVD

SUITE 400

(Street)

SAN JOSE CA 95113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S(1)		5,000	D	$25.86	615,650(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were effected pursuant to a Rule 10b5-1 trading plan dated August 29, 2025.

2. Includes 343,868 RSUs.

Remarks:

	/s /Guy Zeltser, Attorney-in-Fact for Richard McCathron	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hippo (HIPO) disclose for CEO Richard McCathron?

Hippo disclosed that CEO Richard McCathron sold 5,000 shares of Common Stock. The sale was an open-market transaction at $25.86 per share and was executed under a Rule 10b5-1 trading plan dated August 29, 2025.

How many Hippo (HIPO) shares did the CEO sell and at what price?

The CEO sold 5,000 shares of Hippo Common Stock at a price of $25.86 per share. This was an open-market sale reported on a Form 4 insider filing for the transaction dated March 9, 2026.

Was the Hippo (HIPO) CEO’s share sale part of a Rule 10b5-1 plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan dated August 29, 2025. Such plans pre-schedule trades, which can make the timing less indicative of the insider’s short-term market outlook.

How many Hippo (HIPO) shares does the CEO hold after this transaction?

After the reported sale, the CEO directly holds 615,650 shares of Hippo Common Stock. The disclosure notes that this figure includes 343,868 restricted stock units (RSUs), which typically settle into shares over time subject to vesting conditions.

Does the Hippo (HIPO) Form 4 show any option exercises or derivative transactions?

No. The Form 4 shows a single non-derivative transaction: an open-market sale of 5,000 shares of Common Stock. The derivative summary section is empty, indicating no option exercises or other derivative transactions were reported in this filing.

Is the Hippo (HIPO) CEO’s sale a buy or sell signal in the Form 4?

The Form 4 clearly reports a sell transaction, with the CEO disposing of 5,000 shares in an open-market sale. However, the filing notes the trade was made under a pre-arranged Rule 10b5-1 plan, which can reflect routine portfolio management.